Edition:
United Kingdom

FDA Says AurobindoPharma USA Initiates Voluntary Nationwide Consumer Level Recall Expansion Of Valsartan Tablets


Friday, 1 Mar 2019 

March 1 (Reuters) - U.S. Food and Drug Administration::FDA - AUROBINDOPHARMA USA INITIATES VOLUNTARY NATIONWIDE CONSUMER LEVEL RECALL EXPANSION OF 38 LOTS OF AMLODIPINE VALSARTAN TABLETS & VALSARTAN TABLETS.FDA - AUROBINDOPHARMA USA INITIATING RECALL EXPANSION OF 38 LOTS OF AMLODIPINE VALSARTAN, VALSARTAN TABLETS DUE TO DETECTION OF NDEA IMPURITY.